Trupanion, Inc. (NASDAQ:TRUP) Shares Bought by Vanguard Group Inc.

Vanguard Group Inc. raised its holdings in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 1.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,596,725 shares of the financial services provider's stock after acquiring an additional 45,653 shares during the quarter. Vanguard Group Inc. owned 8.49% of Trupanion worth $173,362,000 as of its most recent filing with the SEC.

Other institutional investors also recently made changes to their positions in the company. Wellington Management Group LLP lifted its stake in shares of Trupanion by 4.4% in the third quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider's stock valued at $142,475,000 after purchasing an additional 142,156 shares during the period. FMR LLC grew its position in Trupanion by 55,963.7% during the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider's stock worth $49,213,000 after buying an additional 1,170,202 shares during the period. Baillie Gifford & Co. increased its holdings in Trupanion by 26.6% in the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider's stock valued at $33,806,000 after buying an additional 147,341 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Trupanion by 2.1% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 306,752 shares of the financial services provider's stock valued at $14,785,000 after acquiring an additional 6,338 shares during the period. Finally, Hosking Partners LLP lifted its position in shares of Trupanion by 52.5% during the 4th quarter. Hosking Partners LLP now owns 212,720 shares of the financial services provider's stock valued at $10,253,000 after acquiring an additional 73,203 shares during the period.

Remove Ads

Analysts Set New Price Targets

A number of research firms recently weighed in on TRUP. Stifel Nicolaus lowered their price target on Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a report on Thursday, February 20th. Piper Sandler dropped their price target on Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $46.60.

Trupanion Price Performance

Shares of TRUP traded up $0.65 during mid-day trading on Friday, reaching $35.62. 612,520 shares of the company's stock were exchanged, compared to its average volume of 657,182. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. Trupanion, Inc. has a 52-week low of $19.69 and a 52-week high of $57.90. The company has a market cap of $1.51 billion, a price-to-earnings ratio of -154.87, a PEG ratio of 6.02 and a beta of 1.66. The company has a 50-day simple moving average of $37.85 and a two-hundred day simple moving average of $45.80.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by ($0.02). The company had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. On average, sell-side analysts predict that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.

Insider Activity at Trupanion

In other news, CEO Margaret Tooth sold 2,294 shares of Trupanion stock in a transaction dated Tuesday, March 4th. The shares were sold at an average price of $31.39, for a total transaction of $72,008.66. Following the completion of the sale, the chief executive officer now directly owns 118,784 shares in the company, valued at $3,728,629.76. The trade was a 1.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Fawwad Qureshi sold 1,373 shares of the company's stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total transaction of $46,984.06. Following the transaction, the chief financial officer now directly owns 2,416 shares in the company, valued at $82,675.52. The trade was a 36.24 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 29,792 shares of company stock valued at $989,442. 5.50% of the stock is owned by insiders.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.